Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction


Ercan E., Tengiz I., Duman C., Onbasili O., Baris N.

AMERICAN HEART JOURNAL, cilt.147, 2004 (SCI İndekslerine Giren Dergi) identifier

Özet

Objectives C-reactive protein (CRP) is a prototypic marker of inflammation. The effect of tirofibon on CRP levels in patients with non-ST-elevation myocardial infarction (NSTEMI) was investigated.